BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Research and development (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $2.0B | +8.1% | −14.9% | −1.2% |
| Research and development (TTM) | $2.0B |
|---|---|
| YoY | +8.1% |
| 5-year CAGR | −14.9% |
| 10-year CAGR | −1.2% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $1.8B | −10.2% |
| 2024 | $2.0B | −19.0% |
| 2023 | $2.4B | +9.6% |
| 2022 | $2.2B | −10.8% |
| 2021 | $2.5B | −37.3% |
| 2020 | $4.0B | +75.0% |
| 2019 | $2.3B | −12.2% |
| 2018 | $2.6B | +15.2% |
| 2017 | $2.3B | +14.2% |
| 2016 | $2.0B | −2.0% |
| 2015 | $2.0B | +6.3% |
| 2014 | $1.9B | +31.1% |
| 2013 | $1.4B | +8.2% |
| 2012 | $1.3B | +9.5% |
| 2011 | $1.2B | −2.3% |
| 2010 | $1.2B | −2.7% |
| 2009 | $1.3B | +19.7% |
| 2008 | $1.1B | +15.9% |
| 2007 | $925M | — |